US20060048607A1 - Reagent for rapidly attaining thermal equilibrium in a biological and/or chemical reaction - Google Patents
Reagent for rapidly attaining thermal equilibrium in a biological and/or chemical reaction Download PDFInfo
- Publication number
- US20060048607A1 US20060048607A1 US11/129,930 US12993005A US2006048607A1 US 20060048607 A1 US20060048607 A1 US 20060048607A1 US 12993005 A US12993005 A US 12993005A US 2006048607 A1 US2006048607 A1 US 2006048607A1
- Authority
- US
- United States
- Prior art keywords
- nanoparticles
- reaction
- reagent
- reagent according
- functional group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 69
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 29
- 239000002105 nanoparticle Substances 0.000 claims abstract description 92
- 239000002253 acid Substances 0.000 claims abstract description 22
- 125000000524 functional group Chemical group 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 19
- 229910052751 metal Inorganic materials 0.000 claims abstract description 6
- 239000002184 metal Substances 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 239000010931 gold Substances 0.000 claims description 90
- 238000003752 polymerase chain reaction Methods 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 238000003753 real-time PCR Methods 0.000 claims description 12
- JAJIPIAHCFBEPI-UHFFFAOYSA-N 9,10-dioxoanthracene-1-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)O JAJIPIAHCFBEPI-UHFFFAOYSA-N 0.000 claims description 10
- 239000000084 colloidal system Substances 0.000 claims description 7
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical group OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 4
- 229910004042 HAuCl4 Inorganic materials 0.000 claims description 3
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000006479 redox reaction Methods 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002082 metal nanoparticle Substances 0.000 description 2
- 239000002923 metal particle Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910000666 supertherm Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000010415 colloidal nanoparticle Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0545—Dispersions or suspensions of nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/10—Metallic powder containing lubricating or binding agents; Metallic powder containing organic material
- B22F1/102—Metallic powder coated with organic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2998/00—Supplementary information concerning processes or compositions relating to powder metallurgy
Definitions
- the invention relates to a reagent for a biological and/or chemical reaction; more particularly, to a reagent for rapidly attaining thermal equilibrium in a biological and/or chemical reaction.
- Temperature is an important factor to a biological and/chemical reaction, which has ability to control if a reaction occurs. Temperature regulation is more important to the biological reaction involving biological macromolecules such as nucleic acids or proteins that are highly sensitive to temperature. Only at the specific temperature, the biological macromolecules can maintain specific conformations and then carry out a specific reaction.
- Polymerase chain reaction has a more critical temperature requirement among various biological and/or chemical reactions.
- the material of conventional thermal conduction interface for polymerase chain reaction comprises silicon or aluminum.
- ABI PRISM® 7000 Sequence Detection Systems having a thermal conduction rate of 1 ° C/sec controls the temperature of a reaction solution by adjusting the temperature of a silicon or aluminum bulk with an intermediator of a solution container.
- such apparatus takes a lot of time for performing a reaction.
- the duration of thermal conduction outside the container and the duration of attaining thermal equilibrium inside the container are different, so that the sensitivity of the reaction is not satisfied.
- the present invention provides an effective and economic method for rapidly attaining thermal equilibrium in a biological and/or chemical reaction.
- One object of the invention is to provide a reagent for rapidly attaining thermal equilibrium in a biological and/or chemical reaction, which comprises Au nanoparticles;
- the Au nanoparticles have a Au metal core covalently bonding to a weak acid functional group, and the Au nanoparticles are aqueous.
- Another object of the invention is to provide a method for rapidly attaining thermal equilibrium in a biological and/or chemical reaction, which is characterized in adding the reagent as mentioned above.
- the other object of the invention is to provide a method for producing the reagent as mentioned above, wherein the Au nanoparticles are produced by a method comprising steps of:
- FIG. 1 illustrates the electromicroscopic view of the Au nanoparticles prepared according to the reduction-oxidation reaction.
- FIG. 2 illustrates the absorbance peaks of the Au nanoparticles prepared according to the reduction-oxidation reaction and monitored by the spectrometer.
- FIG. 3 illustrates the particle sizes of the Au nanoparticles in the polymerase chain reaction and monitored by the spectrometer.
- FIG. 4 illustrates the particle sizes of the Au nanoparticles in the polymerase chain reaction and monitored by the electromicroscope.
- FIG. 5 illustrates the electrophoresis results of the products obtained from the polymerase chain reaction with different concentrations of Au nanoparticles.
- FIG. 6 illustrates the results of polymerase chain reaction with different reaction time in the presence of Au nanoparticles
- A, C and E reactions in the absence of Au nanoparticles
- B, D and F reactions in the presence of Au nanoparticles
- a and B reaction time, 60 sec
- C and D reaction time, 40 sec
- E and F reaction time, 20 sec.
- FIG. 7 illustrates the efficiency of real-time polymerase chain reaction in the presence of 10 6 copies per unit of DNA template.
- FIG. 8 illustrates the general efficiency of real-time polymerase chain reaction in the presence of 10 6 copies per unit of DNA template.
- FIG. 9 illustrates the threshold cycle number of real-time polymerase chain reaction in the presence of 10 6 copies per unit of DNA template.
- the present invention provides a reagent for rapidly attaining thermal equilibrium in a biological and/or chemical reaction, which comprises Au nanoparticles;
- the Au nanoparticles have a Au metal core covalently bonding to a weak acid functional group, and the Au nanoparticles are aqueous.
- biological reaction refers to a reaction occurred inside an organism or a reaction carried out by molecules derived from an organism.
- the molecules involved in the biological reaction comprise but are not limited to macromolecules such as nucleotide, peptides, proteins and carbohydrates.
- the biological reaction according to the invention preferably comprises but is not limited to polymerase chain reaction, enzyme digestion, protein hybridization, and nucleotide-protein hybridization; more preferably, comprises polymerase chain reaction; most preferably comprises, real-time polymerase chain reaction.
- chemical reaction refers to a reaction carried out by chemical molecules.
- the chemical reaction according to the invention preferably comprises thermal sensitive reaction.
- the term “Au nanoparticle” refers to a particle composed by gold atom and having a nano degree particle size.
- the term particularly refers to a nanoparticles having an Au metal core covalently bonding to a weak acid functional group, and the Au nanoparticle is aqueous.
- the weak acid functional group is a citric acid group or a tannic acid group; more preferably, the weak acid functional group is a citric acid group.
- the Au nanoparticles preferably have an average particle size in a range of 1 nm to 100 nm; wherein more preferably, the Au nanoparticles have a average particle size in a range of 1 nm to 40 nm.
- the Au nanoparticles are in a colloid solution. In order to apply in various reactions, the colloid solution is preferably neutral in pH and does not change the pH values of the reactions.
- the Au nanoparticles are free particles and suitable for various kinds of reactions.
- the Au nanoparticles according to the invention preferably have a concentration in a range of 10 ⁇ 5 mM to 10 ⁇ 8 mM in the reaction solution; more preferably, the Au nanoparticles have a concentration in a range of 10 ⁇ 6 mM to 10 ⁇ 7 mM in the reaction solution.
- metal nanoparticles having a good thermal conduction property they are broadly used in lubricants.
- common metal nanoparticles cannot be utilized in a biological and/or chemical reaction because they cannot be dissolved in water and often form aggregates.
- Conventionally synthesized colloid metal particles that covalently bind to protectors are aqueous and do not form aggregates, but the metal particles such as Fe and Ag colloid particles cannot improving thermal equilibrium.
- the biological reaction with enzyme involved, such as polymerase chain reaction needs good correlation between thermal conduction and enzyme dynamics. Only the Au nanoparticles according to the invention can be dissolved in water without aggregation and are proven to improving thermal conduction when added into the reaction solutions.
- the aqueous (i.e. without aggregation) Au nanoparticles according to the invention have properties of high thermal conduction and energy cohesion, they are able to improve thermal conduction when added into a biological and/or chemical reaction.
- the Au nanoparticles improve the efficiency and sensitivity of polymerase chain reaction dramatically.
- normal polymerase such as Taq DNA polymerase can catalyze real-time polymerase chain reaction instead of high quality DNA polymerase.
- the Au nanoparticles according to the invention having a large surface area and excellent thermal conduction help to attain thermal equilibrium in 10 to 100 ps.
- the Au nanoparticles sized 10 to 15 nm with a concentration of 10 ⁇ 8 mM are shown to improve the sensitivity of polymerase chain reaction by 10,000-fold, and shorten amplification time by thousands-fold.
- concentration used is much lower than that in the previous thermal conduction study (0.3 to 5%), (J. Z. Zhang, “Ultrafast studies of electron dynamics in semiconductor and metal colloidal nanoparticles:effects of size and surface,” Acc.Chem.Res., Vol. 30, pp. 423-429, 1997; S. Link, C. Burda, Z. L. Wang, and M. A.
- the present invention also provides a method for rapidly attaining thermal equilibrium in a biological and/or chemical reaction, which is characterized in adding the reagent as mentioned above.
- the present invention further provides a method for producing the reagent as mentioned above, wherein the Au nanoparticles are produced by a method comprising steps of:
- the manner in the step (a) for nucleating gold salt with the weak acid functional group is well known to persons skilled in this field.
- Au has ability to form colloid, and then produce aqueous nanoparticles by a reduction-oxidation reaction.
- the weak acid functional group is a citric acid group or a tannic acid group; more preferably, the weak acid functional group is a citric acid group.
- gold salt and citric acid group is used to synthesize aqueous and acidic Au nanoparticles, which is published by M. A. Hayat (M. A. Hayat, Colloidal Gold, Principle, Methods and Applications).
- the gold salt is HAuCl 4
- the citric acid group is preferably Na 3 C 6 H 5 O 7 .2H 2 O.
- Au ion is reduced to Au atom as a crystal seed in the nucleation reaction and then Au nanoparticles grows. When the three-charged ions are exhausted, Au particles stop growth.
- Different sizes of Au nanoparticle can be prepared by changing the ratio of gold salt to citric acid group. For example, when the ratio of gold salt to citric acid group (gold salt:citric acid group) is 5:1, the Au nanoparticles having particle sizes of about 10 to 15 nm are prepared.
- the unreacted weak acid functional group is removed and the Au nanoparticles are obtained in the step (b).
- the conventional method for preparing Au nanoparticles is acidic because the detergent used is acidic. Additionally, the unreacted weak acid functional group is not removed in the conventional methods, so that the conventional Au nanoparticles are not suitable in neutral or basic reactions. Furthermore, the reagents for Au nanoparticles preparation would interfere the reaction. For example, citric acid group is a strong chelator that chelates metal ions (e.g. Mg 2+ ) in the reaction solution.
- the Au nanoparticles can be applied in the biological and/or chemical reaction after the step (b) treatment.
- the method for removing in the step (b) is centrifuge at a high speed.
- the centrifuge condition is well known to artisans skilled in this field.
- the particles are centrifuged at 10,000G for 7 minutes.
- the method according to the invention preferably further comprises a vacuum suction step for concentrating the Au nanoparticles to achieve a desired concentration and pH value.
- HAuCl 4 and Na 3 C 6 H 5 O 7 .2H 2 O in the ratio of 5:1 were used for aqueous nanoparticle preparation.
- the particle size of nanoparticles were monitored by transmission electromicroscope and shown in FIG. 1 . It shows that the particle size of the nanoparticles is 13.7 ⁇ 0.8 nm. The nanoparticles have a strong absorption peak at 520 nm when detected by UV-Vis spectrum (as shown in FIG. 2 ). It also proves that the particle size is about 13 nm.
- the aqueous nanoparticles were subjected to centrifuge at 10,000G for 7 minutes, and then concentrated by vacuum suction to obtain concentrations of 10 ⁇ 4 , 10 ⁇ 5 , 10 ⁇ 6 and 10 ⁇ 7 mM.
- the volume of a single capillary tube is about 20 to 25 ⁇ L, and 32 tests can be carried out at the same time.
- the reaction solution contained 20 ⁇ L of 10 ⁇ PCR buffer, two primers, 200 ⁇ M dNTPs, 0.5 ⁇ g/ ⁇ L BSA, 1/30,000 SYBR® Green I (Roche®), 1 U of Supertherm® Taq DNA polymerase, 2 ⁇ L DNA template, and 2 ⁇ L Au nanoparticles prepared in Example 1.
- the fragments to be amplified were enhanced green fluorescent protein (EGFP) and Bcl-2 and nineteen kda interacting protein-3 (BNIP3) cDNA.
- the primers for EGFP were EGFP-N-S: 5′-TGC AGT GCT TCA GCC GCT AC-3′ (SEQ ID NO. 1) and EGFP-N-AS: 5′-CAG CTC GAT GCG GTT CAC CA-3′ (SEQ ID NO. 2) which amplify a 173-bp fragment from a template pEGFP-N1 (CLONTECH®).
- the ratio of GC content is more than 60%.
- the primers for BNIP3 cDNA are 5′-CGC AGC TGA AGC ACA TCC-3′ (SEQ ID NO.
- the templates for amplifying EGFP and BNIP3 cDNA are 10 2 to 10 9 copies per unit.
- SYBR® Green I dye was used for quantification and F1 mode was chosen for detecting the absorbance at 520 nm wavelength.
- the standard thermal condition of polymerase chain reaction was denaturing at 95° C. for 15 sec, annealing at 58° C. for 15 sec, and extending at 72° C. for 30 sec (total reaction time: 60 sec).
- the dye was detected at 84° C. for 1 sec. Such condition was common for use in a common polymerase chain reaction.
- the reaction time of each stage was reduced in proportion in the example.
- the particle size of the Au nanoparticles in the polymerase chain reaction was monitored by the spectrometer (as shown in FIG. 3 ) and electromicroscope (as shown in FIG. 4 ). It shows that the particle size of the Au nanoparticles does not change and the Au nanoparticles do not form aggregates.
- the effect of the Au nanoparticles at a single temperature was assayed. It shows that the Au nanoparticles do not only improve primer extension involving enzymes but also improve denaturing and annealing involving thermal equilibrium.
- the efficiency of Au nanoparticles in real-time polymerase chain reaction was also observed. 7.52 ⁇ 10 ⁇ 7 mM of Au nanoparticles with different concentrations of templates were subjected to the reactions having reaction time of 60 sec, 40 sec and 20 sec. The result is shown in FIG. 6 . According to FIG. 6 , the products were detected when adding 10 6 to 10 9 copies of template per unit in the reaction in the absence of Au nanoparticles. On the other hand, the products were detected when adding 10 2 to 10 9 copies of template per unit in the reaction in the presence of the Au nanoparticles. When the reaction time was reduced to 40 sec, the products were detected in the reaction with 10 3 to 10 9 copies of template per unit in the presence of the Au nanoparticles.
- the reaction time was reduced to 20 sec, the products were detected in the reaction with 10 9 copies of template per unit in the presence of the Au nanoparticles. On the other hand, the products were detected in the reaction with 10 7 to 10 9 copies of template per unit in the absence of the Au nanoparticles.
- the results show that the Au nanoparticles have ability to enhance the formula for normal polymerase chain reaction with Supertherm® Taq DNA polymerase to be suitable for real-time polymerase chain reaction.
- the amplification curve of the reaction in the presence of 7.52 ⁇ 10 ⁇ 7 mM of Au nanoparticles and 10 6 copies of template is shown in FIGS. 7 and 8 .
- the threshold cycle was accelerated by 11 cycles.
- the slopes were changed from ⁇ 8.566 to ⁇ 4.918. In other words, the efficiency was increased twice (from 0.9017 to 1.59). It proves that the Au nanoparticles improve the efficiency of polymerase chain reaction significantly.
- the effect of the Au nanoparticles concentration on threshold cycle number was assayed with 10 6 copies per unit of template. The result is shown in FIG. 9 . It shows that when the Au nanoparticles concentration are reduced from 10 ⁇ 6 mM to 10 ⁇ 7 mM, the threshold cycle number is eliminated dramatically; i.e. the efficiency is improved and the reaction is accelerated. The optimum concentrations of the Au nanoparticles of 10 ⁇ 6 mM to 10 ⁇ 7 mM were obtained thereby.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW093113876 | 2004-05-17 | ||
| TW093113876A TW200538548A (en) | 2004-05-17 | 2004-05-17 | The method of biological and/or chemical reaction to fast reach thermally-equilibrium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20060048607A1 true US20060048607A1 (en) | 2006-03-09 |
Family
ID=35994883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/129,930 Abandoned US20060048607A1 (en) | 2004-05-17 | 2005-05-16 | Reagent for rapidly attaining thermal equilibrium in a biological and/or chemical reaction |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US20060048607A1 (enExample) |
| TW (1) | TW200538548A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104607654A (zh) * | 2015-02-10 | 2015-05-13 | 济南大学 | 一种基于银纳米颗粒的自组装材料及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6180372B1 (en) * | 1997-04-23 | 2001-01-30 | Bruker Daltonik Gmbh | Method and devices for extremely fast DNA replication by polymerase chain reactions (PCR) |
-
2004
- 2004-05-17 TW TW093113876A patent/TW200538548A/zh not_active IP Right Cessation
-
2005
- 2005-05-16 US US11/129,930 patent/US20060048607A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6180372B1 (en) * | 1997-04-23 | 2001-01-30 | Bruker Daltonik Gmbh | Method and devices for extremely fast DNA replication by polymerase chain reactions (PCR) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104607654A (zh) * | 2015-02-10 | 2015-05-13 | 济南大学 | 一种基于银纳米颗粒的自组装材料及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI350852B (enExample) | 2011-10-21 |
| TW200538548A (en) | 2005-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12351859B2 (en) | Methods for the epigenetic analysis of DNA, particularly cell-free DNA | |
| CN101200716B (zh) | 使用聚多卡醇和衍生物的核酸分离 | |
| US20070238096A1 (en) | Hybrid energy transfer for nucleic acid detection | |
| EP2494073B1 (de) | Konjugate von nukleotiden und methoden zu deren anwendung | |
| US20250154607A1 (en) | Isothermal amplification of pathogens | |
| EP0838528A1 (en) | Method for measuring the concentration of polynucleotides | |
| JP2010539982A (ja) | チェイスライゲーション配列決定法 | |
| Zhou et al. | Dual-amplified CRISPR-Cas12a bioassay for HIV-related nucleic acids | |
| WO2004111602A2 (en) | Colorimetric and fluorescent methods for sensing of oligonucleotides | |
| CN117504806A (zh) | 改进的磁性粒子及其用途 | |
| JP4050870B2 (ja) | Dnaの合成方法 | |
| US11130987B2 (en) | Direct detection of RNA by surface initiated enzymatic polymerization | |
| JP2007306914A (ja) | 単一のマイクロチャンバで核酸の濃縮および増幅を行う方法、ならびに該方法を行う装置 | |
| US8557568B2 (en) | Method and apparatus for disrupting cells and amplifying nucleic acids using gold nanorods | |
| Wan et al. | The effects of gold nanoparticles with different sizes on polymerase chain reaction efficiency | |
| CN117321221A (zh) | 病原体的等温扩增 | |
| US7371530B2 (en) | Micro PCR device, method for amplifying nucleic acids using the micro PCR device, and method for measuring concentration of PCR products using the micro PCR device | |
| JP2018516072A (ja) | シトラコン酸無水物によって微生物を不活性化する方法 | |
| Oberc et al. | Nucleic acid amplification test (NAAT) conducted in a microfluidic chip to differentiate between various ginseng species | |
| JP5572943B2 (ja) | 血液検体からのdna増幅方法及びdna増幅キット | |
| JP2012010666A (ja) | 核酸合成用酵素組成物及び核酸合成法 | |
| EP0989192A2 (en) | Method for synthesis of nucleic acids | |
| Pan et al. | Nanomaterials-based polymerase chain reactions for DNA detection | |
| Seyyedi et al. | High yield gold nanoparticle‐based DNA isolation method for human papillomaviruses genotypes from cervical cancer tissue samples | |
| Sang et al. | Quantum dots for a high-throughput Pfu polymerase based multi-round polymerase chain reaction (PCR) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: NATIONAL CHENG KUNG UNIVERSITY, TAIWAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIN, YU-CHENG;LI, MIN;WU, CHAO-CHIN;REEL/FRAME:016702/0576;SIGNING DATES FROM 20050516 TO 20050517 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |